ERAS Stock Analysis: Buy, Sell, or Hold?
ERAS - Erasca, Inc. Common Stock
$10.13
-0.10 (-0.98%)
▼
5d:
-2.97%
30d:
-46.71%
90d:
-18.63%
HOLD
MODERATE Confidence
Analysis Updated: May 18, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Smart Money Accumulation
ERAS is down 4.0% this week, but smart money is accumulating calls. Top strike: $12.5 2026-07-17 with 4,247 OI. Call ratio: 74% View Scanner →
Strength: 4.5/10
Get Alerted When ERAS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called ERAS this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ERAS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ERAS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ERAS is currently trading at $10.13, which is considered slightly low relative to its 30-day fair value range of $9.67 to $19.34.
Technical Outlook: Technically, ERAS is in a uptrend. Immediate support is located at $9.77, while resistance sits at $10.93.
Market Sentiment: ERAS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $20.30 (+98.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ERAS is in a uptrend. Immediate support is located at $9.77, while resistance sits at $10.93.
Market Sentiment: ERAS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $20.30 (+98.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$9.67 -
$19.34
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding ERAS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 98.4% below Wall St target ($20.30)
Trading Range Analysis
30-Day Trading Range
$9.67 -
$19.34
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$9.77
Resistance Level
$10.93
Current Trend
Uptrend
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-18.14
Wall Street Target
$20.30
(+98.4%)
Share & Embed Analysis
Last updated: May 18, 2026 1:50 PM ET
Data refreshes hourly during market hours. Next update: 2:50 PM
Data refreshes hourly during market hours. Next update: 2:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ERAS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Ebun Garner
SELL
80000 shares
2026-04-01
Shannon Morris
SELL
20000 shares
2026-03-04
Ebun Garner
SELL
120000 shares
2026-01-07
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 50 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$242 | 64 BUY |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$118 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 53 HOLD |
Advanced ERAS Option Strategies
Professional options setups generated by AI based on today's ERAS price and gamma walls.
